n=8 diagnosed AD cases (500 mg of sectionable frozen block, hippocampal formation), specific cases NACC246954, NACC220100, NACC448049, NACC487467, NACC497314,
NACC577944, NACC766623, and NACC784642, as collected under UCSD IRB 170957,
Role: PD/PI,
University of California, San Diego,
Status: Awarded
Federal
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists- Administrative Supplement (Multiplex Platform),
Role: PD/PI,
National Institutes of Health/DHHS,
(09/2020 - 08/2021)
Status: Awarded
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists,
Role: PD/PI,
National Institutes of Health/DHHS,
(06/2019 - 02/2024)
Status: Closed
Internal
Residual account for Dr. Talbot managed by Research Affairs Post Award.,
Role: PD/PI,
LLU Dept. of Neurosurgery,
(01/2020 - 12/2024)
Status: Awarded